Quoin Pharmaceuticals Submits IND Application to US FDA for QRX003

▤ Summary

Quoin Pharmaceuticals submitted an Investigational New Drug application to the US FDA for QRX003. The available text does not include additional details about the program, trial timeline, or expected next steps. This is a regulatory milestone rather than a software or corporate transaction event. The news is relevant to readers tracking pharma industry activity, but it does not indicate a software product release or company restructuring.

▦ Linked Companies